Novavax Stock- COVID live updates: 1,000 aged care facilities, nearly 1 million Australians have received first dose of vaccine
What are our options in terms of vaccines?
Are there back ups to the astrazeneca vaccine if it turns out the clotting is an issue? Even if we just do something similar to the UK and don’t give it to under 30s, what alternatives are available to us? We don’t have any other types of vaccines coming…
-Worried young person
Hi, Worried young person.
There are actually three vaccines that the Australian Government has been pursuing.
This is what the Federal Government says about it on its website:
Novavax is developing a vaccine for Coronavirus (COVID-19). If the vaccine is proven to be safe and effective and is approved for use, it will be available in Australia as early as the first half of 2021 as part of the Australian Government’s COVID-19 Vaccine and Treatment Strategy. It is expected that 51 million doses will be made available in Australia during 2021, which will supply enough doses to cover Australia’s whole population. Doses for Australia will be manufactured in several locations across Europe.
So, what’s happening with this?
Well, at the moment, not much.
The Government said that it is meant to be available in Australia “as early as the first half of 2021”.
That seems unlikely, although the TGA is currently evaluating its early data.
The contract with Novavax does not have a timeline though, and the Sydney Morning Herald today reported that it could be months before vaccines are on Australian shores.
Not only that, but there are no guarantees of supply for Australia.
A company spokesman told the ABC: “At the present time, Novavax are not specifying which of their global manufacturing locations will supply the Novavax COVID-19 vaccine”.
There’s also the Johnson and Johnson vaccine, which has sent an application to the Therapeutic Goods Administration for provisional registration of its vaccine in Australia.
But the Australian government has not confirmed any deals with the company — yet.
“The World Health Organization think it’s a very good vaccine,” Professor Tony Cunningham, from Sydney’s Westmead Institute, told the Specialist Reporting Team’s Nick Sas.
“They think that it’s also ideal for the developing world because it’s one shot. And you’re getting high efficacy and it’s easily reachable.”
Professor Cunningham says it is likely many other vaccines will emerge over the coming years as the virus evolves, and he urges the public to be patient.
“Remember that six months ago we weren’t even sure we would have a vaccine, so where we are now is really quite extraordinary.”